期刊文献+

人类与病原菌的军备竞赛:NDM-1耐药基因与超级细菌 被引量:17

Arms racing between human beings and pathogens:NDM-1 and superbugs
原文传递
导出
摘要 在人类历史上,每一次诸如鼠疫和肺结核病等瘟疫的大流行,都曾给人类的生存带来巨大的威胁。抗生素的应用使人类掌握了抵抗细菌感染的锐利"武器",但同时病原菌也通过突变和水平基因转移等方式产生了诸多耐药基因,从而获得了应对抗生素杀伤的坚固"盾牌";于是人类又不断地开发新式抗生素"武器"来破解病原菌的耐药"盾牌"——一场"军备竞赛"愈演愈烈。近来研究发现,携带编码NDM-1基因的耐药质粒不仅可以在细菌间转移,而且能使所在宿主菌成为可以耐受几乎全部抗生素的超级细菌。但是,凭借着日益进步的科技和医学,以及科学的用药策略,我们一定可以再次战胜超级细菌。 Throughout human history,pandemic bacterial diseases such as the plague and tuberculosis have posed an enormous threat to human beings.The discovery of antibiotics has provided us with powerful arsenal for the defense against bacterial infections.However,bacteria are acquiring more and more resistance genes to shield off antibiotics through mutation and horizontal gene transfer.Therefore,novel antibiotics must be produced and the arms race between bacterial pathogens and antibiotics is becoming increasingly intense.Recently,researchers have found that plasmids carrying a new metallo-β-lactamase gene,blaNDM-1,and many other antibiotics resistance genes can easily spread through bacterial populations and confer recipient stains resistance to nearly all of the current antibiotics.It is a threat to the human health and a great challenge for our medical science,which we are facing.We need to find new ways to fight and win this arms racing.
出处 《生物工程学报》 CAS CSCD 北大核心 2010年第11期1461-1472,共12页 Chinese Journal of Biotechnology
基金 国家自然科学基金项目(No.30770060) 国家自然科学基金创新研究群体科学基金(No.81021003)资助~~
关键词 NDM-1 超级细菌 军备竞赛 耐药基因 NDM-1 superbugs arms racing resistance gene
  • 相关文献

参考文献77

  • 1Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis, 2010, 10(9): 597-602.
  • 2Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother, 2009, 53(12): 5046-5054.
  • 3Paterson DL. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Infect Control, 2006, 34(5 Suppl 1): $20-28; discussion S64-73.
  • 4Agency HP. Multi-resistant hospital bacteria linked to India and Pakistan. Health Protection Report, 2009, 3(26): 3-4.
  • 5Fleming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc Lond B Biol Sci, 1922, 93: 306-317.
  • 6Fleming A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol, 1929, 10:226-236.
  • 7Pasteur L, Joubert JF. Charbon et septicemie. C R Soc Biol (Paris), 1877, 85: 101-115.
  • 8Babes V, Comil J. MedPrat (Paris), 1885, 7: 321.
  • 9Garre C. Ueber Antagonisten unter den bacterien. Correspondenz-Blatt fiir Schweizer Aerzte, 1887, 17: 385-392.
  • 10Emmerich. R, Low O. Bakteriolytische Enzyme als Ursache der erworbenen Immunitat und die Heilung von Infektionskrankheiten durch dieselben. Z Hyg InfektKr, 1899, 31: 1.

同被引文献286

引证文献17

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部